pyrroles has been researched along with amodiaquine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Basilico, N; Casagrande, M; Parapini, S; Romeo, S; Sparatore, A; Taramelli, D | 1 |
| Almeras, L; Amalvict, R; Baret, E; Briolant, S; Gil, M; Henry, M; Parquet, V; Pradines, B; Rogier, C; Wurtz, N | 1 |
| Aas, PA; Afset, JE; Biza, S; Bjørås, M; Erlandsen, SE; Fenstad, MH; Hagen, L; Ianevski, A; Kainov, DE; Landsem, VM; Lysvand, H; Løseth, K; Malmring, JF; Nordbø, SA; Oksenych, V; Pettersen, CH; Reisberg, T; Tenson, T; Yao, R; Zusinaite, E | 1 |
3 other study(ies) available for pyrroles and amodiaquine
| Article | Year |
|---|---|
Novel amodiaquine congeners as potent antimalarial agents.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship | 2008 |
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Topics: Amodiaquine; Antimalarials; Atorvastatin; Chloroquine; DNA, Protozoan; Drug Synergism; Gene Dosage; Genotype; Heptanoic Acids; Humans; Inhibitory Concentration 50; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles | 2010 |
Potential Antiviral Options against SARS-CoV-2 Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Therapy, Combination; Emetine; HEK293 Cells; Homoharringtonine; HT29 Cells; Humans; Immune Sera; Immunization, Passive; Indoles; Nelfinavir; Neutralization Tests; Pandemics; Pneumonia, Viral; Pyrans; Pyrroles; SARS-CoV-2; Vero Cells | 2020 |